Review data on the latest ARV regimens and paradigms and where they may fit into HIV patient management strategies.
Watch this on-demand video capture of an EACS 2019 satellite symposium. Expert faculty engage in case-based discussion to highlight where newer ART regimens fit into current HIV practice in both the first-line and switch settings.
EACS 2019 will feature updated ART guidance and new data on HIV management. Here’s a sneak preview of our expert-led symposium on integrating these and other recent developments into the clinic when selecting regimens for treatment-naive and virologically suppressed patients.
Here’s my take on which clinical data and patient parameters should be considered before making an ART switch in the context of virologic suppression.
With longer-term data now available, our understanding of the use for 2-drug regimens in first-line and maintenance ART settings has expanded. Here’s my take on how that affects practice.
As increasing evidence links certain highly efficacious ARVs with weight gain, clinicians must consider remaining key questions and their subsequent approach to patients with HIV.